Trials / Completed
CompletedNCT05521919
Acute Plasma Abeta Responses to Stress
Effects of Acute Stress Exposure on Plasma Beta-amyloid Levels
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- University of Southern California · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Research has shown that activation of the sympathetic nervous system for extended periods or during certain times in life can increase the risk for Alzheimer's disease. Some research in animal models show that acute activation of the sympathetic nervous system through stress exposure can increase certain Alzheimer's disease-related biomarkers, such as amyloid-beta, within hours of exposure. However, how acute sympathetic nervous system activation via stress exposure affects amyloid-beta levels in humans has yet to be examined. In this study, the investigators will examine whether brief increases in sympathetic activation result in immediate changes in plasma amyloid-beta levels in the five hours after exposure.
Detailed description
Aim 1: determine whether acute exposure to stress (increasing sympathetic nervous system activation) increases plasma amyloid-beta-40 and amyloid-beta-42 in the five hours following exposure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Sympathetic Nervous System Activation | Participants will complete a task that increases sympathetic nervous system activation. |
| BEHAVIORAL | No-stress | Participants will complete a task that will not affect their sympathetic nervous system activity. |
Timeline
- Start date
- 2023-12-05
- Primary completion
- 2024-12-10
- Completion
- 2024-12-10
- First posted
- 2022-08-30
- Last updated
- 2025-12-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05521919. Inclusion in this directory is not an endorsement.